Activity

Filter

Cancel
Date Panel Item Activity
11 actions
Ectodermal Dysplasia v0.65 GRHL2 Zornitza Stark Publications for gene: GRHL2 were set to 25152456
Ectodermal Dysplasia v0.64 GRHL2 Zornitza Stark Classified gene: GRHL2 as Green List (high evidence)
Ectodermal Dysplasia v0.64 GRHL2 Zornitza Stark Gene: grhl2 has been classified as Green List (High Evidence).
Ectodermal Dysplasia v0.63 GRHL2 Ain Roesley changed review comment from: 2 more unrelated probands with ectodermal dysplasia/short stature syndrome. Originally described in PMID: 19415813; to: 2 more unrelated probands with ectodermal dysplasia/short stature syndrome. 1x originally described in PMID: 19415813
Ectodermal Dysplasia v0.63 GRHL2 Ain Roesley edited their review of gene: GRHL2: Changed rating: GREEN; Changed mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Ectodermal Dysplasia v0.63 GRHL2 Ain Roesley reviewed gene: GRHL2: Rating: ; Mode of pathogenicity: None; Publications: 27612988, 19415813; Phenotypes: Ectodermal dysplasia/short stature syndrome MIM#616029; Mode of inheritance: None; Current diagnostic: yes
Ectodermal Dysplasia v0.52 GRHL2 Bryony Thompson Marked gene: GRHL2 as ready
Ectodermal Dysplasia v0.52 GRHL2 Bryony Thompson Gene: grhl2 has been classified as Amber List (Moderate Evidence).
Ectodermal Dysplasia v0.52 GRHL2 Bryony Thompson Classified gene: GRHL2 as Amber List (moderate evidence)
Ectodermal Dysplasia v0.52 GRHL2 Bryony Thompson Gene: grhl2 has been classified as Amber List (Moderate Evidence).
Ectodermal Dysplasia v0.51 GRHL2 Bryony Thompson gene: GRHL2 was added
gene: GRHL2 was added to Ectodermal Dysplasia. Sources: NHS GMS
Mode of inheritance for gene: GRHL2 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: GRHL2 were set to 25152456
Phenotypes for gene: GRHL2 were set to Ectodermal dysplasia/short stature syndrome MIM#616029
Review for gene: GRHL2 was set to AMBER
Added comment: Two unrelated consanguineous families with homozygous missense variants and some supporting assays on keratinocytes from cases.
Sources: NHS GMS